Composition containing tarc, and method for improving storage stability of tarc
AssigneeSekisui Medical Co., Ltd.
InventorsAkiko MATSUMOTO, Tomoyuki USUI, Yuka SUZUKI, Kengo FUJIMURA
Life of this patent
Estimating the term…
Abstract
An object of the present invention is to provide a TARC-containing composition with high storage stability. Provided is a composition including TARC (Thymus and activation-regulated chemokine) and one or more selected from the group consisting of a sugar fatty acid ester-type nonionic surfactant, a polyoxyethylene-polyoxypropylene block copolymer-type nonionic surfactant, and a polyoxyethylene alkylamine-type nonionic surfactant and being in liquid form. The aforementioned object is achieved by the composition.
Claims20
A composition comprising:
- TARC (Thymus and activation-regulated chemokine);
- and
- one or more selected from the group consisting of a sugar fatty acid ester-type nonionic surfactant, a polyoxyethylene-polyoxypropylene block copolymer-type nonionic surfactant, and a polyoxyethylene alkylamine-type nonionic surfactant, and
- being in liquid form.
A method for improving storage stability of TARC, comprising a step of contacting TARC with a solution containing one or more selected from the group consisting of a sugar fatty acid ester-type nonionic surfactant, a polyoxyethylene-polyoxypropylene block copolymer-type nonionic surfactant, and a polyoxyethylene alkylamine-type nonionic surfactant.
An adsorption inhibitor for preventing adsorption of TARC in a solution containing TARC onto a container, comprising one or more selected from the group consisting of a sugar fatty acid ester-type nonionic surfactant, a polyoxyethylene-polyoxypropylene block copolymer-type nonionic surfactant, and a polyoxyethylene alkylamine-type nonionic surfactant, as active component.
Dependencies are inferred from the claim text.